These findings indicate potential involvement of local thyroid hormone action in breast cancer progression, as DIO3 is the primary thyroid hormone inactivating enzyme, and DIO1 plays a crucial role in the deiodination of T4 to T3 [33]. Here, DIO3 is linked to breast carcinoma.